logo
Dr. Jyotsna Suri Leading India's Tourism Renaissance on the Global Stage

Dr. Jyotsna Suri Leading India's Tourism Renaissance on the Global Stage

New Delhi [India], June 24: Dr. Jyotsna Suri, Chairperson and Managing Director of The LaLiT Suri Hospitality Group, offers her expert perspective on the evolving trends shaping India's travel and hospitality landscape.
As international tourist arrivals continue to fall short of expectations, Dr. Suri calls for a bold new approach to how India presents itself on the world stage, emphasizing the need for innovative marketing, infrastructure improvements, and the creation of new destinations to truly unlock the country's tourism potential.
While India's domestic tourism scene is bustling, international tourism hasn't quite bounced back as strongly as many had hoped. Even as the world's overall tourism numbers recover, India is still seeing fewer foreign visitors compared to the pre-pandemic era. In 2023, for example, only about 9.5 million foreign tourists arrived in India—a figure that remains over 10% below the nearly 11 million recorded in 2019, according to Skift. The trend hasn't improved much by mid-2024, with just 4.8 million foreign arrivals in the first six months.
When Dr. Jyotsna Suri speaks about the future of India's tourism sector, one thing stands out above all: the urgent need to put India on the global map through bold and consistent marketing.
She points out that, despite the country's incredible diversity and rich experiences, India simply isn't being marketed as aggressively as it should be. 'Right now, we are not being marketed at all,' she says, stressing that a well-funded, ministry-led campaign could quickly change the narrative and attract a wider range of international visitors.
While progress on infrastructure upgrades is encouraging, Dr. Suri admits it will take time before India's facilities truly match world-class standards; still, she is heartened by the direction things are moving and the ongoing investments being made.
She also highlights the importance of developing new destinations, not just for drawing in foreign tourists but for giving domestic travellers fresh places to explore. Many existing spots remain underutilised, and new attractions could help spread out the crowds and ease pressure on popular sites.
When it comes to competing with neighbours like Thailand and Indonesia, Dr. Jyotsna Suri acknowledges that India might be a bit pricier in some areas, especially with GST factored in, but she firmly believes the country delivers outstanding value for money—something that discerning travellers appreciate. A shift is happening, where the focus is moving from attracting backpackers to courting higher-spending, quality tourists who are looking for unique and enriching experiences.
The Indian government has launched several key initiatives to attract more international tourists, focusing on developing 50 major destinations to enhance infrastructure and provide a better visitor experience. Visa reforms, including streamlined e-visa processes and fee waivers for select travellers, are making it easier for tourists to visit India.
Additionally, programs promoting spiritual, heritage, and medical tourism highlight the country's unique cultural and wellness offerings. Efforts to improve regional connectivity through schemes like UDAN are opening up access to lesser-known destinations, making India more accessible overall.
Dr. Jyotsna Suri praised the combined efforts of the central and state governments, including leadership from the Prime Minister, Home Minister, and Chief Ministers, for their commitment to revitalising tourism. 'It will happen soon. It'll take time, but it will happen,' she said, expressing optimism about the future and India's potential to emerge as a top global destination.
With the right strategies and sustained effort, India can not only compete with its neighbours but also emerge as a leading global destination for all types of travellers.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NxtQuantum AI-powered 5G smartphones to be next market giant-killer
NxtQuantum AI-powered 5G smartphones to be next market giant-killer

Business Standard

time15 minutes ago

  • Business Standard

NxtQuantum AI-powered 5G smartphones to be next market giant-killer

Currently, the cheapest 5G smartphones in India are priced above ₹8,000. Sheth's latest offering promises not just affordability, but also compatibility with standalone and non-standalone 5G networks premium Surajeet Das Gupta New Delhi Listen to This Article Madhav Sheth, founder of NxtQuantum Shift Technologies and the man behind Realme's meteoric rise in India, is laying the groundwork to launch an ultra-affordable, AI-powered 5G smartphone, priced under ₹ 5,000. Currently, the cheapest 5G smartphones in India are priced above ₹8,000. Sheth's latest offering promises not just affordability, but also compatibility with standalone and non-standalone 5G networks. 'We don't have a truly successful Indian smartphone brand today — that's the gap we're aiming to fill,' Sheth told Business Standard, who after quitting Realme tried bringing back the Honor brand to India with limited success. 'Our goal is to sell

Torrent to buy 46.39 pc stake in JB Chemicals for Rs 11,917 crore
Torrent to buy 46.39 pc stake in JB Chemicals for Rs 11,917 crore

Indian Express

time16 minutes ago

  • Indian Express

Torrent to buy 46.39 pc stake in JB Chemicals for Rs 11,917 crore

In a significant acquisition in the pharmaceutical sector, Torrent Pharmaceuticals Ltd on Sunday entered into definitive agreements to acquire controlling stake of 46.39 per cent stake in J. B. Chemicals and Pharmaceuticals from global investment firm KKR for Rs 11,917 crore at a price of Rs 1,600 per share. Torrent will also make a mandatory open offer to acquire another 26 per cent of JB Pharma shares from public shareholders at an open offer price of Rs 1,639.18 per share. After the open offer, the total cost of acquisition will come to Rs 13,556 crore. The acquisition was made at an equity valuation of Rs 25,689 crore (on fully diluted basis), followed by a merger of the two entities. The transaction marks a significant step in Torrent's ambition to create a future-ready, diversified healthcare platform combining a deep chronic segment heritage with emerging international CDMO (contract development and manufacturing organization) capabilities. As per the approval given by the board of directors of both companies, after the merger of JB Pharma with Torrent, every shareholder holding 100 shares in JB Pharma will receive 51 shares of Torrent. In addition to this, Torrent has also expressed its intent to acquire up to 2.80% of equity shares from certain employees of JB Pharma at the same price per share as KKR. The merger between Torrent and JB Pharma will be through a scheme of arrangement. KKR, a US-based private equity giant, acquired about 54 per cent stake in JB Chemicals and Pharmaceuticals, one of the oldest pharma companies in India, for Rs 3,100 crore in July 2020. It acquired the stake from the founding Mody family at a purchase price of Rs 745 per share and made an open offer for an additional 26 per cent of the company. Samir Mehta, Executive chairman, Torrent, said: 'Torrent's deep India presence and JB Pharma's fast growing India business, combined with the CDMO and international footprint offers immense potential to scale both revenue and profitability. This strategic alignment furthers our goal of strengthening our presence in the Indian pharma market, and build a larger diversified global presence. Moreover, the CDMO platform provides a new long-term avenue of growth for Torrent.' Torrent Pharma, which has a market valuation of Rs 1.13 lakh crore, closed higher by 3.68 per cent at Rs 3344.40 on the BSE on Friday. JB Chemicals, with a market capitalisation of Rs 28,080 crore, reported a revenue of Rs 3,722 crore in FY25. Its shares closed 2.72 per cent higher at Rs 1799.35 on the BSE. Torrent Pharma, with annual revenues of more than Rs 11,500 crore, is the flagship company of the Torrent Group, with group revenues of Rs 45,000 crore. It is amongst the top 5 in the therapeutics segments of cardiovascular (CV), gastro Intestinal (GI), central nervous system (CNS) and cosmo-dermatology. It is a specialty-focused company with 76 per cent of its revenues in India from chronic and sub- chronic therapies. It has presence in 50 plus countries. Torrent has 8 manufacturing facilities, of which 5 are USFDA approved. JB Pharma is one of the fastest growing pharmaceutical companies in India and a leading player in the hypertension segment. Besides its strong India presence, which accounts for majority of its revenue, its other two home markets are Russia and South Africa. In India, the company has six brands among the top 300 IPM brands in the country. It has eight state-of-the-art manufacturing facilities in India including a dedicated manufacturing facility for lozenges

‘GoIStats' mobile app launched for real-time access to official statistical data
‘GoIStats' mobile app launched for real-time access to official statistical data

Hans India

time17 minutes ago

  • Hans India

‘GoIStats' mobile app launched for real-time access to official statistical data

New Delhi: The government on Sunday launched the 'GoIStats' mobile application that will help every stakeholder seamlessly access official data on the go. The initiative by the National Sample Survey Office (NSO), under the Ministry of Statistics and Programme Implementation (MoSPI), is a significant milestone in India's commitment to making official statistics accessible and user-centric for all citizens. The GoIStats mobile application represents NSO's vision of creating an all-encompassing data ecosystem. The application features an interactive "Key Trends" dashboard showcasing important socio-economic indicators with dynamic visualisations of critical metrics including GDP, inflation, employment data. Users gain direct access to NSO's database through the "Products" section, featuring one-click CSV downloads. Advanced filtering and search capabilities with comprehensive metadata, and mobile-optimised data tables are also available for seamless viewing, according to the ministry. The app's visual data storytelling capabilities include a curated infographics section that transforms complex statistics into digestible insights, interactive charts and graphs with contextual explanations, social sharing features to promote data literacy across communities, and complete source attribution for each visualisation following principles of transparency and trust. Moreover, a comprehensive publication section provides users with the access to NSO reports and publications with instant download functionality. Regular updates aligned with NSO's publication calendar are provided to the user with app notification facility. Feedback mechanism for continuous app improvement, a user-friendly interface and direct communication channels through the "Contact Us" section are some of the features designed for user empowerment. Currently the Android version of mobile application is available free of charge on google play store. The iOS version will be released shortly. 'This initiative completes the ideal digital bouquet of website, portal and mobile app expected from a data producing organisation. GoIStats empowers every Indian to meaningfully engage with government data, strengthening citizen participation in building a Viksit Bharat,' said the ministry.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store